Application

The US Food and Drug Administration has accepted for Priority Review a supplemental biologic license application for Tzield (teplizumab-mzwv) to expand its age indication to include children as young as …

Introduction Diabetes mellitus (DM) is a long-term chronic disease. According to recently published data from the International Diabetes Federation, the number of people worldwide suffering from diabetes has reached 451 …